BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chaves-Moreira D, Mitchell MA, Arruza C, et al. (2022) The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17. Science Signaling. 15: eabm2496
Cunningham JM, Winham SJ, Wang C, et al. (2021) DNA Methylation Profiles of Ovarian Clear Cell Carcinoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology
Xu H, George E, Kinose Y, et al. (2021) copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models. Cell Reports. Medicine. 2: 100394
Wu S, Fukumoto T, Lin J, et al. (2021) Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. Nature Cancer. 2: 189-200
Gysler SM, Drapkin R. (2021) Tumor innervation: peripheral nerves take control of the tumor microenvironment. The Journal of Clinical Investigation. 131
Barger CJ, Chee L, Albahrani M, et al. (2021) Co-regulation and function of / bidirectional genes in cancer. Elife. 10
Mauro LJ, Seibel MI, Diep CH, et al. (2021) Progesterone Receptors Promote Quiescence & Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models. The Journal of Clinical Endocrinology and Metabolism
Tangri A, Lighty K, Loganathan J, et al. (2021) Deubiquitinase UCHL1 Maintains Protein Homeostasis through the PSMA7-APEH-Proteasome Axis in High-Grade Serous Ovarian Carcinoma. Molecular Cancer Research : McR
Burston HE, Kent OA, Communal L, et al. (2021) Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer. The Journal of Clinical Investigation
Ferrari AJ, Drapkin R, Gogna R. (2021) Cell Fitness: More Than Push-Ups. International Journal of Molecular Sciences. 22
See more...